alexa Prevalence of Tuberculosis and Diabetes | Open Access Journals
ISSN: 2161-1068
Mycobacterial Diseases
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Prevalence of Tuberculosis and Diabetes

Armindo Tiago1 and Damiano Pizzol2*

1Department of Physiology, Mondlane University, Maputo, Mozambique

2Operational Research Unit, Doctors with Africa Cuamm, Beira, Mozambique

Corresponding Author:
Damiano Pizzol
Operational Research Unit
Doctors with Africa Cuamm, Beira, Mozambique
Tel: +39-3668731237
E-mail: [email protected]

Received Date: May 10, 2017; Accepted Date: May 15, 2017; Published Date: May 22, 2017

Citation: Tiago A, Pizzol D (2017) Prevalence of Tuberculosis and Diabetes. Mycobact Dis 7:238. doi:10.4172/2161-1068.1000238

Copyright: © 2017 Tiago A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Mycobacterial Diseases

Letter to Editor

Dear Editor,

Tuberculosis (TB) is one of the leading causes of death worldwide and, although great efforts have already been made, the way to defeat this disease is still long [1]. The burden of TB is higher in Sub-Saharan Africa and low income countries where, another increasing plague, the diabetes mellitus (DM) is affecting more and more people. The rapid increase of DM and its coexistence with TB and HIV is a clear example of overlap and interaction between communicable and noncommunicable diseases requiring a multidisciplinary and integrated approach [2]. The association between TB and DM, in particular in low and medium income countries, has been showed to cause a mutual worsening of the natural history of both diseases. Although the pathophysiological mechanism is still unclear, it has been observed that each disease may adversely affect the outcomes of the other, in terms of delayed diagnosis and healing, severity of symptoms, mortality [2]. However, to date, contrasting data are available regarding TB prevalence in diabetes and vice versa and, recent findings suggest a high burden of diabetes among TB patients but low prevalence of TB among DM patients [3]. Apparently, this is a contrast that could be partially explained by social determinants of health (SDH). In fact, growing evidence suggests that the lack of efficacy in containing TB and the presence of multi drug resistance (MDR), is due to many factors including SDH [4]. SDH are defined as conditions in which people are born, grow, live, work and get old having an immediate impact on health and are greatly influenced by the distribution of money, power and resources [5]. In particular, low education, low income and alcohol abuse are significant predictors of therapy failure and MDR in people with TB.

On one hand, in fact, the high prevalence of DM in TB patients is a consequence of increased susceptibility. In fact, malnutrition and physical inactivity lead patients with TB to stimulate adrenaline, glucagon and cortisol at the same time, thus increasing glucose levels [6]. Moreover, the higher incidence of chronic calcified pancreatitis in patients with TB and vitamin A, C and D deficiencies might also explain the impaired glucose tolerance and increased risk of DM [7].

On the other hand, although diabetes seems to be a “risk factor” for TB, affecting innate as well as adaptive immune responses [8], the presence of diabetes in many cases, especially in developing countries, is to mean a well-being state and, thus, good SDH.

Regardless of the pathophysiologic basis, especially in developing countries, both diseases are increasing and represent a huge health, social and economic burden. For this reason, it is mandatory to strengthen the efforts in two main aspects: clinic and scientific.

In fact, on one side, it is necessary to develop integrated and multidisciplinary approaches in order to improve the prevention, the screening and the management of dual diseases. Moreover, to achieve more effective results, it is also critical to perform early diagnosis, treatment and management of co-morbidities and, regarding latent TB, preventive therapy.

On the other side, the complexity of the association between TB and DM requires a great effort from the scientific community to clarify the many outstanding issues and to develop appropriate and adequate strategies of health policies in different settings.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 74
  • [From(publication date):
    June-2017 - Jul 24, 2017]
  • Breakdown by view type
  • HTML page views : 55
  • PDF downloads :19
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords